Efficacy News and Research

RSS
Cannabinoid therapy helps provide effective analgesia for cancer patients with pain

Cannabinoid therapy helps provide effective analgesia for cancer patients with pain

Sapio announces availability of Exemplar Biomarker Discovery LIMS

Sapio announces availability of Exemplar Biomarker Discovery LIMS

Ipsen, Active Biotech present OS data from tasquinimod Phase II study on CRPC at ASCO 2012

Ipsen, Active Biotech present OS data from tasquinimod Phase II study on CRPC at ASCO 2012

Exelixis reports data from cabozantinib phase 3 trial on MTC

Exelixis reports data from cabozantinib phase 3 trial on MTC

Promising data from Array BioPharma’s MEK162 Phase 2 trial on BRAF and NRAS mutant melanoma

Promising data from Array BioPharma’s MEK162 Phase 2 trial on BRAF and NRAS mutant melanoma

OncoGenex announces data from OGX-427 Phase 2 study on mCRPC

OncoGenex announces data from OGX-427 Phase 2 study on mCRPC

Positive results from BioSpecifics’ XIAFLEX Phase III clinical program on Peyronie's disease

Positive results from BioSpecifics’ XIAFLEX Phase III clinical program on Peyronie's disease

Ambit, Astellas commence quizartinib Phase 2b trial in relapsed/refractory AML

Ambit, Astellas commence quizartinib Phase 2b trial in relapsed/refractory AML

Adamas to present update on Nurelin program at CHI Targeting Parkinson's Disease Symposium

Adamas to present update on Nurelin program at CHI Targeting Parkinson's Disease Symposium

Aeterna Zentaris announces results from perifosine Phase 3 trial on colorectal cancer

Aeterna Zentaris announces results from perifosine Phase 3 trial on colorectal cancer

Polynoma initiates POL 103A Phase III trial in melanoma

Polynoma initiates POL 103A Phase III trial in melanoma

Advaxis to update preliminary data on ADXS-HPV Phase 2 trial for cervical cancer

Advaxis to update preliminary data on ADXS-HPV Phase 2 trial for cervical cancer

Oncothyreon announces data from two clinical trials of PX-866 at ASCO meeting

Oncothyreon announces data from two clinical trials of PX-866 at ASCO meeting

New data from OncoMed’s OMP-59R5 Phase I study on advanced solid tumors

New data from OncoMed’s OMP-59R5 Phase I study on advanced solid tumors

Results from Puma’s PB272 Phase I combination trial on metastatic HER-2 positive breast cancer

Results from Puma’s PB272 Phase I combination trial on metastatic HER-2 positive breast cancer

Genentech’s T-DM1 Phase III study on HER2-positive mBC meets primary endpoint

Genentech’s T-DM1 Phase III study on HER2-positive mBC meets primary endpoint

New research: Foggers ineffective against bed bugs

New research: Foggers ineffective against bed bugs

Favorable results from CytRx’s INNO-206 Phase 1b/2 trial on soft tissue sarcomas

Favorable results from CytRx’s INNO-206 Phase 1b/2 trial on soft tissue sarcomas

Socioeconomic status of patient linked to choice of treatment

Socioeconomic status of patient linked to choice of treatment

Lapatinib-pazopanib combination therapy not beneficial for patients with inflammatory breast cancer

Lapatinib-pazopanib combination therapy not beneficial for patients with inflammatory breast cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.